ESGCT 2025 | European Society for Gene & Cell Therapy

Aaron walked away with triple the insights from this conversation at #ESGCT2025 with three passionate early-career researchers from the European Society for Gene and Cell Therapy 💡💡💡 Marija Tomovic from Naples, Juliette Lemoine from Paris, and Stefano Gritti from London shared their excitement for gene editing, AAV therapies, and treatments for rare immune diseases.

Their energy was contagious as they shared breakthroughs in gene editing delivery, exciting advances in IV gene therapy trials, and innovative ways to repair and regenerate cells.

They also reflected on what makes #ESGCT special: collaboration, insight, and a vibrant community that inspires early-career researchers. Their advice? Chase what excites you, keep an open mind to every opportunity, and build connections—it’s where innovation sparks!

Previous
Previous

ESGCT 2025 | Viralgen Aava Platform

Next
Next

ESGCT 2025 | British Society for Gene & Cell Therapy